0001104659-15-013577.txt : 20150224
0001104659-15-013577.hdr.sgml : 20150224
20150224211416
ACCESSION NUMBER: 0001104659-15-013577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150221
FILED AS OF DATE: 20150224
DATE AS OF CHANGE: 20150224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legault Pierre
CENTRAL INDEX KEY: 0001391045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 15645702
MAIL ADDRESS:
STREET 1: P.O. BOX 1028
STREET 2: C/O STONE MANAGEMENT LLC
CITY: BERWYNE
STATE: PA
ZIP: 19312
4
1
a4.xml
4
X0306
4
2015-02-21
1
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001391045
Legault Pierre
P.O. BOX 1028
C/O STONE MANAGEMENT LLC
BERWYNE
PA
19312
1
0
0
0
Stock Options (right to buy)
27.29
2015-02-21
4
D
0
20257
D
2024-11-03
Common Stock
20257
0
D
Restricted Stock Units
2015-02-21
4
D
0
3816
D
Common Stock
3816
0
D
On November 3, 2014, the stock options were granted with one fourth vesting on the first anniversary of date of grant and 6.25% vesting on each quarterly anniversary thereafter.
In connection with the merger of Knight Newco 2, Inc. with and into NPS Pharmaceuticals, Inc. (the "Issuer") on February 21, 2015, each outstanding stock option, whether vested or unvested, was cancelled in exchange for a single lump sum cash payment in an amount equal to the product of (1) the number of shares of the Issuer's common stock subject to such stock option and (2) the execess, if any, of $46.00 over the exercise price per share of such stock option.
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
On February 12, 2015, the Restricted Stock Units were granted with one hundred percent vesting on the first anniversary of date of grant.
In connection with the merger of Knight Newco 2, Inc. with and into the Issuer on February 21, 2015, each outstanding Restricted Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Restricted Stock Unit.
/s/ Pierre Legault, by Jill Thompson as attorney-in-fact
2015-02-24